跳至主要内容
临床试验/TCTR20220517004
TCTR20220517004招募中4 期

ong term efficiency of azelastine hydrochloride and fluticasone propionate nasal spray to improve PAP adherence in patients with obstructive sleep apnea.

/A0 个研究点目标入组 116 人开始时间: 2022年5月17日最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
116

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 70 Years(—)
性别
All

入选标准

  • 1. New patients who are diagnosed as Obstructive sleep apnea and benefit form CPAP device use according to physician decision in Thammasat hospital., 2. Patient can use CPAP device at home, 3. Age 18 to 70 years old, 4. Patient who first visit at Thammasat hospital since January 2022, 5. Pateints who had been registered to study Efficiency of azelastine hydrochloride and fluticasone propionate nasal spray to improve PAP adherence in patients with obstructive sleep apnea.

排除标准

  • 1. Impair cognitive function, 2. Already used intranasal steroid, 3. Have others sleep problems such as Nacrolepsy, Insomnia, Parasomnia or Central sleep apnea. 4. Allergy to Azelastine HCl and Fluticasone proprionate, 5. Could not reading and writing

研究者

发起方
/A

相似试验

ong term efficiency of azelastine hydrochloride and... | 临床试验